Bayer delivers on medical innovation fueling transformation of pharma business
The Pharma Data
FEBRUARY 21, 2022
Bayer’s research and development pipeline continues to grow as the company is building on its existing competencies, such as the expertise around small molecules, while expanding into new modalities, including cell and gene therapies. “We Re-imagining Radiology.
Let's personalize your content